News

US$444,000 of Debentures matured on August 1, 2025. An additional US$175,000 will mature on August 31, 2025. The Company is current on all interest payments. In respect of the Warrants, 2,637,582 ...
Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") is pleased to announce that, further to its news releases of July 17 and July 29, 2025, it has closed a heavily ...
July 31, 2025) - Further to its press release dated July 24, 2025, Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") wishes to provide an update regarding its ...
With the app Substage, users can type out file management tasks in plain English, then use the commands it generates to ...